L.A. McKeown
Senior Medical Journalist at TCTMD
Senior Medical Journalist @TCTMD; Section Editor, CV Team Forum; my favorite title is Mom
Articles
-
1 week ago |
tctmd.com | L.A. McKeown
The test of nonaerobic functioning may raise awareness that people need to work on balance and flexibility as they age. The ability to lower yourself to the floor and get back up without using your hands may be a risk predictor for natural and cardiovascular mortality, Brazilian researchers say.
-
1 week ago |
tctmd.com | L.A. McKeown
The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring. While the long-term risk of CVD in cancer survivors can vary significantly based on cancer type and treatment, the overall incidence may be lower than previously suspected, data from Danish population-based registries suggest.
-
2 weeks ago |
tctmd.com | L.A. McKeown
Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most. On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more evidence of for a potential vascular benefit.
-
3 weeks ago |
tctmd.com | L.A. McKeown
Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron. Numerous knowledge gaps exist regarding the care of female patients with cardiogenic shock, often because they have been consistently underrepresented in clinical trials, according to a new consensus statement from the Society for Cardiovascular Angiography and Interventions (SCAI).
-
3 weeks ago |
tctmd.com | L.A. McKeown
Thinking outside the box is needed to spark greater enrollment of women in research endeavors historically dominated by men. Removing some of the seen and unseen barriers that keep women out of clinical trials—by taking steps to tackle their concerns head-on and empower them in decision-making—may go a long way toward improving female participants’ recruitment into cardiovascular research, according to a joint British Cardiovascular Societies’ consensus document.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 812
- Tweets
- 2K
- DMs Open
- No
RT @crfheart: We are deeply saddened by the loss of our dear friend and colleague, Dimitri Karmpaliotis. A gifted interventionalist, devote…
A "dedicated and intentional shift in how we approach clinical research" is needed to generate robust, sex-specific evidence needed to optimize care for women with cardiogenic shock. @SuzanneJBaron @SCAI https://t.co/JzpbD5INVF
"Raising awareness that cardiovascular disease is the number one killer for women is so important, because many women and men are not aware of this." @VijayKunadian @DrMarthaGulati @Gurleen_Kaur96 https://t.co/ixY8hIrqMz